Immune Checkpoint Blockade Improves Chemotherapy in the PyMT Mammary Carcinoma Mouse Model

Immune Checkpoint Blockade Improves Chemotherapy in the PyMT Mammary Carcinoma Mouse Model

Despite the success of immune checkpoint blockade in cancer, the number of patients that benefit from this revolutionary treatment option remains low. Therefore, efforts are being undertaken to sensitize tumors for immune checkpoint blockade, which includes combining immune checkpoint blocking agent...

Full description

Bibliographic Details
Main Authors: Evelyn Sirait-Fischer, Catherine Olesch, Annika F. Fink, Matthias Berkefeld, Arnaud Huard, Tobias Schmid, Kazuhiko Takeda, Bernhard Brüne, Andreas Weigert
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-09-01
Series:Frontiers in Oncology
Subjects:
cancer
immunotherapy
chemotherapy
immune checkpoint
cytotoxic lymphocytes
Online Access:https://www.frontiersin.org/article/10.3389/fonc.2020.01771/full

Internet

https://www.frontiersin.org/article/10.3389/fonc.2020.01771/full

Similar Items